VolitionRx Limited Selling and Marketing Expense
VolitionRx Limited (VNRX) reported Selling and Marketing Expense of $548.51 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-13
- VolitionRx Limited selling and marketing expense for the quarter ending 2026-06-30 was $548.51K, a 47.44% decline year-over-year.
- VolitionRx Limited selling and marketing expense for the quarter ending 2026-03-31 was $851.85K, a 7.13% decline year-over-year.
- VolitionRx Limited selling and marketing expense for the quarter ending 2025-12-31 was $1.00M, a 19.97% decline year-over-year.
- VolitionRx Limited selling and marketing expense for the quarter ending 2025-09-30 was $958.57K, a 9.02% decline year-over-year.
- VolitionRx Limited selling and marketing expense for fiscal 2025 was $3.92M, a 26.91% decline from fiscal 2024.
- VolitionRx Limited selling and marketing expense for fiscal 2024 was $5.36M, a 21.61% decline from fiscal 2023.
- VolitionRx Limited selling and marketing expense for fiscal 2023 was $6.84M, a 4.06% increase from fiscal 2022.
- VolitionRx Limited selling and marketing expense for fiscal 2022 was $6.58M, a 76.58% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $548.51K 10-Q · filed 2026-08-13 | $1.40M 10-Q · filed 2026-08-13 | $2.40M derived: sum of 3 quarters · filed 2026-08-13 | $3.36M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $851.85K 10-Q · filed 2026-05-14 | $1.85M derived: sum of 2 quarters · filed 2026-05-14 | $2.81M derived: sum of 3 quarters · filed 2026-05-14 | $3.86M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.96M derived: sum of 2 quarters · filed 2026-03-31 | $3.00M derived: sum of 3 quarters · filed 2026-08-13 | $3.92M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $958.57K 10-Q · filed 2025-11-13 | $2.00M derived: sum of 2 quarters · filed 2026-08-13 | $2.92M 10-Q · filed 2025-11-13 | $4.17M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $1.04M 10-Q · filed 2026-08-13 | $1.96M 10-Q · filed 2026-08-13 | $3.21M derived: sum of 3 quarters · filed 2026-08-13 | $4.27M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $917.30K 10-Q · filed 2026-05-14 | $2.17M derived: sum of 2 quarters · filed 2026-05-14 | $3.22M derived: sum of 3 quarters · filed 2026-05-14 | $4.61M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.31M derived: sum of 2 quarters · filed 2026-03-31 | $3.69M derived: sum of 3 quarters · filed 2026-03-31 | $5.36M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $1.05M 10-Q · filed 2025-11-13 | $2.44M derived: sum of 2 quarters · filed 2025-11-13 | $4.11M 10-Q · filed 2025-11-13 | $6.01M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $1.39M 10-Q · filed 2025-08-14 | $3.06M 10-Q · filed 2025-08-14 | $4.96M derived: sum of 3 quarters · filed 2025-08-14 | $6.53M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $1.67M 10-Q · filed 2025-05-15 | $3.57M derived: sum of 2 quarters · filed 2025-05-15 | $5.14M derived: sum of 3 quarters · filed 2025-05-15 | $6.81M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.47M derived: sum of 2 quarters · filed 2025-03-31 | $5.14M derived: sum of 3 quarters · filed 2025-03-31 | $6.84M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $1.57M 10-Q · filed 2024-11-14 | $3.24M derived: sum of 2 quarters · filed 2024-11-14 | $4.94M 10-Q · filed 2024-11-14 | $6.62M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $1.67M 10-Q · filed 2024-08-14 | $3.38M 10-Q · filed 2024-08-14 | $5.05M derived: sum of 3 quarters · filed 2024-08-14 | $6.58M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $1.71M 10-Q · filed 2024-05-13 | $3.39M derived: sum of 2 quarters · filed 2024-05-13 | $4.91M derived: sum of 3 quarters · filed 2024-05-13 | $6.68M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $3.20M derived: sum of 2 quarters · filed 2024-03-25 | $4.98M derived: sum of 3 quarters · filed 2024-03-25 | $6.58M 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | $1.52M 10-Q · filed 2023-11-14 | $3.30M derived: sum of 2 quarters · filed 2023-11-14 | $4.90M 10-Q · filed 2023-11-14 | $6.72M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $1.77M 10-Q · filed 2023-08-14 | $3.37M 10-Q · filed 2023-08-14 | $5.19M derived: sum of 3 quarters · filed 2023-08-14 | $6.03M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $1.60M 10-Q · filed 2023-05-10 | $3.42M derived: sum of 2 quarters · filed 2023-05-10 | $4.25M derived: sum of 3 quarters · filed 2023-05-10 | $4.81M derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $2.65M derived: sum of 2 quarters · filed 2023-03-15 | $3.22M derived: sum of 3 quarters · filed 2023-03-15 | $3.72M 10-K · filed 2023-03-15 | $4.13M 10-K · filed 2022-03-30 | |||
| 2021-09-30 | $836.65K 10-Q · filed 2022-11-14 | $715.04K 10-Q · filed 2021-11-10 | $1.40M derived: sum of 2 quarters · filed 2022-11-14 | $1.91M 10-Q · filed 2022-11-14 | $1.60M 10-Q · filed 2021-11-10 | $2.16M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $561.91K 10-Q · filed 2022-08-10 | $459.37K 10-Q · filed 2021-08-11 | $886.77K 10-Q · filed 2022-08-10 | $1.33M derived: sum of 3 quarters · filed 2022-08-10 | $1.57M derived: sum of 4 quarters · filed 2022-08-10 | |||
| 2021-03-31 | $427.40K 10-Q · filed 2022-05-11 | $766.41K derived: sum of 2 quarters · filed 2022-05-11 | $1.01M derived: sum of 3 quarters · filed 2022-05-11 | $1.23M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $339.01K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $583.52K derived: sum of 2 quarters · filed 2022-03-30 | $799.41K derived: sum of 3 quarters · filed 2022-03-30 | $1.07M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $244.51K 10-Q · filed 2021-11-10 | $460.40K derived: sum of 2 quarters · filed 2021-11-10 | $734.36K 10-Q · filed 2021-11-10 | $982.02K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $215.89K 10-Q · filed 2021-08-11 | $489.85K 10-Q · filed 2021-08-11 | $737.51K derived: sum of 3 quarters · filed 2021-08-11 | $933.15K derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $273.95K 10-Q · filed 2021-05-11 | $521.62K derived: sum of 2 quarters · filed 2021-05-11 | $717.26K derived: sum of 3 quarters · filed 2021-05-11 | $955.38K derived: sum of 4 quarters · filed 2021-05-11 | ||||
| 2019-12-31 | $247.67K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $443.31K derived: sum of 2 quarters · filed 2021-03-22 | $681.43K derived: sum of 3 quarters · filed 2021-03-22 | $965.71K 10-K · filed 2021-03-22 | ||||
| 2019-09-30 | $195.64K 10-Q · filed 2020-11-12 | $433.76K derived: sum of 2 quarters · filed 2020-11-12 | $718.05K 10-Q · filed 2020-11-12 | $1.04M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $238.12K 10-Q · filed 2020-08-13 | $522.40K 10-Q · filed 2020-08-13 | $846.91K derived: sum of 3 quarters · filed 2020-08-13 | $1.11M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $284.28K 10-Q · filed 2020-05-07 | $608.78K derived: sum of 2 quarters · filed 2020-05-07 | $868.09K derived: sum of 3 quarters · filed 2020-05-07 | $1.10M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $324.50K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $583.80K derived: sum of 2 quarters · filed 2020-02-20 | $819.17K derived: sum of 3 quarters · filed 2020-02-20 | $1.17M 10-K · filed 2020-02-20 | ||||
| 2018-09-30 | $259.30K 10-Q · filed 2019-11-12 | $494.67K derived: sum of 2 quarters · filed 2019-11-12 | $845.25K 10-Q · filed 2019-11-12 | $1.03M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $235.37K 10-Q · filed 2019-08-12 | $599.51K 10-Q · filed 2019-08-12 | $773.74K derived: sum of 3 quarters · filed 2019-08-12 | $959.53K derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | $364.14K 10-Q · filed 2019-05-08 | $538.37K derived: sum of 2 quarters · filed 2019-05-08 | $724.17K derived: sum of 3 quarters · filed 2019-05-08 | $931.21K derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | $174.23K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $360.02K derived: sum of 2 quarters · filed 2019-03-13 | $567.07K derived: sum of 3 quarters · filed 2019-03-13 | $836.47K 10-K · filed 2019-03-13 | $763.41K 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $185.79K 10-Q · filed 2018-11-07 | $134.74K 10-Q · filed 2017-11-09 | $392.84K derived: sum of 2 quarters · filed 2018-11-07 | $662.25K 10-Q · filed 2018-11-07 | $435.97K 10-Q · filed 2017-11-09 | $760.37K derived: sum of 4 quarters · filed 2018-11-07 | ||
| 2017-06-30 | $207.04K 10-Q · filed 2018-08-13 | $152.64K 10-Q · filed 2017-08-10 | $476.45K 10-Q · filed 2018-08-13 | $301.24K 10-Q · filed 2017-08-10 | $574.57K derived: sum of 3 quarters · filed 2018-08-13 | $663.56K derived: sum of 4 quarters · filed 2018-08-13 | ||
| 2017-03-31 | $269.41K 10-Q · filed 2018-05-10 | $148.59K 10-Q · filed 2017-05-11 | $367.53K derived: sum of 2 quarters · filed 2018-05-10 | $456.52K derived: sum of 3 quarters · filed 2018-05-10 | $585.24K derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $98.12K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $187.11K derived: sum of 2 quarters · filed 2018-03-01 | $315.83K derived: sum of 3 quarters · filed 2018-03-01 | $347.71K 10-K · filed 2018-03-01 | ||||
| 2016-09-30 | $88.99K 10-Q · filed 2017-11-09 | $217.71K derived: sum of 2 quarters · filed 2017-11-09 | $249.59K 10-Q · filed 2017-11-09 | |||||
| 2016-06-30 | $128.72K 10-Q · filed 2017-08-10 | $160.60K 10-Q · filed 2017-08-10 | ||||||
| 2016-03-31 | $31.88K 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |